ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
2,1,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
3,1,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
4,1,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
5,1,Pleural effusion,Pneumothorax and pleural effusions NEC,Pleural disorders,Resp,N
5,2,Pulmonary embolism,Pulmonary thrombotic and embolic conditions,Pulmonary vascular disorders,Resp,N
5,3,Respiratory failure,Respiratory failures (excl neonatal),Respiratory disorders NEC,Resp,N
5,4,Vena cava thrombosis,Vena caval embolism and thrombosis,Embolism and thrombosis,Vasc,N
6,1,Flushing,Peripheral vascular disorders NEC,Vascular disorders NEC,Vasc,N
6,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
6,3,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
7,1,Venous thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
8,1,Dermatitis exfoliative generalised,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
8,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
9,1,Diarrhoea haemorrhagic,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
9,2,Haematemesis,Non-site specific gastrointestinal haemorrhages,Gastrointestinal haemorrhages NEC,Gastr,N
10,1,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
10,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
11,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
12,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
13,1,Thrombosis,Non-site specific embolism and thrombosis,Embolism and thrombosis,Vasc,N
14,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
15,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
16,1,Ageusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
16,2,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
16,3,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
16,4,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
16,5,Night sweats,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
17,1,Anaphylactic reaction,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
18,1,Erythema,Erythemas,Epidermal and dermal conditions,Skin,N
18,2,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
19,1,Phlebitis,Phlebitis NEC,Vascular infections and inflammations,Vasc,N
20,1,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
20,2,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
21,1,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
21,2,Dry mouth,Oral dryness and saliva altered,Salivary gland conditions,Gastr,N
21,3,Dystonia,Dystonias,Movement disorders (incl parkinsonism),Nerv,N
21,4,Lymphadenopathy,Lymphatic system disorders NEC,"Spleen, lymphatic and reticuloendothelial system disorders",Blood,N
21,5,Thirst,Feelings and sensations NEC,General system disorders NEC,Genrl,N
21,6,Tongue dry,Tongue signs and symptoms,Tongue conditions,Gastr,N
22,1,Sudden hearing loss,Hearing losses,Hearing disorders,Ear,N
23,1,Mouth ulceration,Stomatitis and ulceration,Oral soft tissue conditions,Gastr,N
24,1,General physical condition abnormal,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
24,2,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
25,1,Drug dependence,Substance related and addictive disorders,Psychiatric disorders NEC,Psych,N
25,2,Dysgraphia,Cortical dysfunction NEC,Neurological disorders NEC,Nerv,N
25,3,Emotional poverty,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
25,4,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
25,5,Suicidal ideation,Suicidal and self-injurious behaviour,Suicidal and self-injurious behaviours NEC,Psych,N
25,6,Withdrawal syndrome,Withdrawal and rebound effects,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
26,1,Lip swelling,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
26,2,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
27,1,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
27,2,Hepatic function abnormal,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
28,1,Foetal exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
28,2,Foetal growth restriction,Foetal growth complications,Foetal complications,Preg,N
29,1,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
29,2,Cholestasis,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
29,3,Exposure during pregnancy,"Exposures associated with pregnancy, delivery and lactation","Exposures, chemical injuries and poisoning",Inj&P,N
29,4,Haemorrhage in pregnancy,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
29,5,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
29,6,Live birth,"Normal pregnancy, labour and delivery","Pregnancy, labour, delivery and postpartum conditions",Preg,N
29,7,Placental insufficiency,Placental abnormalities (excl neoplasms),"Placental, amniotic and cavity disorders (excl haemorrhages)",Preg,N
29,8,Premature baby,Gestational age and weight conditions,Neonatal and perinatal conditions,Preg,N
29,9,Premature separation of placenta,Haemorrhagic complications of pregnancy,Maternal complications of pregnancy,Preg,N
29,10,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
29,11,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
30,1,Infusion site erythema,Infusion site reactions,Administration site reactions,Genrl,N
30,2,Infusion site extravasation,Infusion site reactions,Administration site reactions,Genrl,N
30,3,Infusion site pain,Infusion site reactions,Administration site reactions,Genrl,N
30,4,Infusion site swelling,Infusion site reactions,Administration site reactions,Genrl,N
31,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
31,2,Sepsis,"Sepsis, bacteraemia, viraemia and fungaemia NEC",Infections - pathogen unspecified,Infec,N
32,1,Administration site discolouration,Administration site reactions NEC,Administration site reactions,Genrl,N
32,2,Administration site extravasation,Administration site reactions NEC,Administration site reactions,Genrl,N
32,3,Administration site induration,Administration site reactions NEC,Administration site reactions,Genrl,N
32,4,Administration site pain,Administration site reactions NEC,Administration site reactions,Genrl,N
32,5,Administration site plaque,Administration site reactions NEC,Administration site reactions,Genrl,N
33,1,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
33,2,Loss of consciousness,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,3,Somnolence,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
33,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,1,Headache,Headaches NEC,Headaches,Nerv,N
34,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
34,3,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
35,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
35,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
36,1,Death,Death and sudden death,Fatal outcomes,Genrl,Y
37,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,2,Body temperature increased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
37,3,Nasopharyngitis,Upper respiratory tract infections,Infections - pathogen unspecified,Infec,N
37,4,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
38,1,Blood alkaline phosphatase increased,Tissue enzyme analyses NEC,Enzyme investigations NEC,Inv,N
39,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
40,1,Accidental overdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
40,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,1,Asthenia,Asthenic conditions,General system disorders NEC,Genrl,N
41,2,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
41,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
41,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
42,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
42,2,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
43,1,Accidental underdose,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
44,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
45,1,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
45,2,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
46,1,Drug hypersensitivity,"Allergies to foods, food additives, drugs and other chemicals",Allergic conditions,Immun,N
46,2,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
46,3,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
46,4,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
46,5,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
47,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
47,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
47,3,Wrong technique in product usage process,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
48,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
49,1,Vulvovaginal candidiasis,Candida infections,Fungal infectious disorders,Infec,N
50,1,Headache,Headaches NEC,Headaches,Nerv,N
50,2,Headache,Headaches NEC,Headaches,Nerv,N
50,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,4,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
51,1,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
52,1,Limb mass,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
52,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
52,3,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
52,4,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
52,5,Peripheral swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
52,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
53,1,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
53,2,Swelling,General signs and symptoms NEC,General system disorders NEC,Genrl,N
54,1,Fatigue,Asthenic conditions,General system disorders NEC,Genrl,N
54,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
55,1,Toxic epidermal necrolysis,Bullous conditions,Epidermal and dermal conditions,Skin,N
56,1,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
57,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
58,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
58,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
58,3,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
59,1,Feeling abnormal,Feelings and sensations NEC,General system disorders NEC,Genrl,N
59,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
60,1,Hypocalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
60,2,Paraesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
60,3,Tetany,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
60,4,Therapy non-responder,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
61,1,Muscle spasms,Muscle related signs and symptoms NEC,Muscle disorders,Musc,N
62,1,Anal ulcer,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
62,2,Anal ulcer haemorrhage,Anal and rectal ulcers and perforation,Gastrointestinal ulceration and perforation,Gastr,N
63,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
64,1,Lethargy,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
64,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
64,3,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
64,4,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
64,5,Sleep disorder,Sleep disorders NEC,Sleep disorders and disturbances,Psych,N
65,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
66,1,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,1,Alanine aminotransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
67,2,Blood creatinine increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
67,3,Blood magnesium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
67,4,Blood phosphorus decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
67,5,Blood potassium decreased,Mineral and electrolyte analyses,"Water, electrolyte and mineral investigations",Inv,N
67,6,Blood triglycerides increased,Triglyceride analyses,Lipid analyses,Inv,N
67,7,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
67,8,Cholelithiasis,Cholecystitis and cholelithiasis,Gallbladder disorders,Hepat,N
67,9,Dehydration,Total fluid volume decreased,Electrolyte and fluid balance conditions,Metab,N
67,10,Drug intolerance,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
67,11,Electrolyte imbalance,Electrolyte imbalance NEC,Electrolyte and fluid balance conditions,Metab,N
67,12,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
67,13,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
67,14,Klebsiella test positive,Bacteria identification and serology (excl mycobacteria),Microbiology and serology investigations,Inv,N
67,15,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
68,1,Infection,Infections NEC,Infections - pathogen unspecified,Infec,N
68,2,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
68,3,Pyrexia,Febrile disorders,Body temperature conditions,Genrl,N
69,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
70,1,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
71,1,Blood urea increased,Renal function analyses,Renal and urinary tract investigations and urinalyses,Inv,N
71,2,Emotional distress,Emotional and mood disturbances NEC,Mood disorders and disturbances NEC,Psych,N
71,3,Hypercalcaemia,Calcium metabolism disorders,"Bone, calcium, magnesium and phosphorus metabolism disorders",Metab,N
71,4,Hypernatraemia,Sodium imbalance,Electrolyte and fluid balance conditions,Metab,N
71,5,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
72,1,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
73,1,Methaemoglobinaemia,Haematological disorders,Haematological disorders NEC,Blood,N
74,1,Dysgeusia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
74,2,Headache,Headaches NEC,Headaches,Nerv,N
75,1,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
75,2,Device issue,Device issues NEC,Device issues,Prod,N
75,3,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
76,1,Abdominal discomfort,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
76,2,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
76,3,Epigastric discomfort,Dyspeptic signs and symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,4,Feeling cold,Feelings and sensations NEC,General system disorders NEC,Genrl,N
76,5,Hyperhidrosis,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
76,6,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
76,7,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
77,1,Gastrointestinal stoma output abnormal,Gastrointestinal function diagnostic procedures,Gastrointestinal investigations,Inv,N
77,2,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
78,1,Injection site erythema,Injection site reactions,Administration site reactions,Genrl,N
79,1,Chills,Feelings and sensations NEC,General system disorders NEC,Genrl,N
79,2,Hypothermia,Body temperature altered,Body temperature conditions,Genrl,N
79,3,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
80,1,Medication error,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
80,2,Productive cough,Coughing and associated symptoms,Respiratory disorders NEC,Resp,N
81,1,Product dose omission issue,Product administration errors and issues,Medication errors and other product use errors and issues,Inj&P,N
81,2,Weight decreased,Physical examination procedures and organ system status,Physical examination and organ system status topics,Inv,N
